on a mobile?
 
vTap
    Loading...
 
 
Video
Eli Lilly will acquire Imclone for $70 a share, reports CNBC's Mike Huckman
1m 34s |
3 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Eli Lilly and Company
CNBC
Go to Feed to see what's new!
share
keep
 
 
Eli Lilly buys imclone. Eli Lilly CEO, John Lechleiter talks about the deal to purchase Imclone for $70 per share.
5m 34s |
3 months ago
FOX Business
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Carl Icahn
Cheryl Casone
ImClone Systems
Go to Feed to see what's new!
share
keep
 
 
262
Insight on the the pharmaceutical giant's purchase of ImClone and discussing the economy, with John Lechleiter, Eli Lilly CEO
2 months ago
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Pharmaceutical company
New York Giants
ImClone Systems
Go to Feed to see what's new!
share
keep
 
 
Eli Lilly CEO, John Lechleiter on economy. Eli Lilly CEO, John Lechleiter explains how the state of the economy will affect the company and the purchase of ImClone.
5m 51s |
2 months ago
FOX Business
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Health care
ImClone Systems
Go to Feed to see what's new!
share
keep
 
 
Eli Lilly completes a deal to buy ImClone, reports CNBC's Mike Huckman
3m 36s |
3 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
CNBC
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
John Lechleiter, chief executive officer of Eli Lilly & Co., talks with Bloomberg's Carol Massar and Julie Hyman from Indianapolis about the drugmaker's agreement to buy ImClone Systems Inc. for $6.5 billion. Lilly's $70-a-share bid for ImClone, the biotechnology company controlled by billionaire Carl Icahn, tops Bristol-Myers Squibb Co.'s hostile bid of $62 a share. (Source: Bloomberg)
3 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Eli Lilly and Company
ImClone Systems
Chief executive officer
Pharmaceutical company
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use